🇺🇸 FDA
Pipeline program

4D-150 IVT

4D-150-C001

Phase 2 mab active

Quick answer

4D-150 IVT for Neovascular (Wet) Age-Related Macular Degeneration is a Phase 2 program (mab) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
4D Molecular Therapeutics
Indication
Neovascular (Wet) Age-Related Macular Degeneration
Phase
Phase 2
Modality
mab
Status
active

Clinical trials